In the News

The Situation: As the industry has moved to externalize more functional areas of R&D, one leading pharmaceutical company decided to rethink the associated information management strategy. Processes and information flows that were once second nature were now very different depending on the collaborating external partner and the agreed roles, processes, and information movement required for a contracted work effort. With increasing volume and varieties of work – experiments, studies, trials, programs – being externalized, and the number of partners with varying technical capabilities, the increasing information flow was becoming overwhelming. Older systems and infrastructure no longer supported the way the business had evolved and a new strategy was required.